PAI
AZN icon

Pittenger & Anderson Inc’s AstraZeneca AZN Stock Holding History

Pittenger & Anderson Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15M Sell
32,459
-13
-0% -$2.44K 0.22% 98
2026
Q1 		$6.4M Buy
32,472
+12
+0% +$2.31K 0.25% 91
2025
Q4 		$5.97M Buy
32,460
+150
+0.5% +$26.3K 0.23% 94
2025
Q3 		$4.96M Buy
32,310
+6,687
+26% +$1.01M 0.18% 111
2025
Q2 		$3.58M Sell
25,623
-4,680
-15% -$656K 0.13% 125
2025
Q1 		$4.45M Sell
30,303
-68
-0.2% -$9.84K 0.16% 112
2024
Q4 		$3.98M Buy
30,371
+3,682
+14% +$515K 0.14% 117
2024
Q3 		$4.16M Buy
26,689
+3,295
+14% +$532K 0.16% 113
2024
Q2 		$3.65M Buy
23,394
+6,421
+38% +$966K 0.15% 118
2024
Q1 		$2.3M Buy
16,973
+16,895
+21,660% +$2.24M 0.09% 132
2023
Q4 		$10.4K Buy
+78
New +$10.1K ﹤0.01% 368
2016
Q4 		– Sell
-1,725
Closed -$113K – 370
2016
Q3 		$113K Hold
1,725
– – 0.01% 239
2016
Q2 		$104K Sell
1,725
-11,925
-87% -$693K 0.01% 244
2016
Q1 		$769K Sell
13,650
-6,315
-32% -$379K 0.09% 166
2015
Q4 		$1.36M Hold
19,965
– – 0.17% 140
2015
Q3 		$1.27M Hold
19,965
– – 0.17% 140
2015
Q2 		$1.27M Hold
19,965
– – 0.16% 145
2015
Q1 		$1.37M Buy
19,965
+2,475
+14% +$172K 0.18% 137
2014
Q4 		$1.23M Buy
17,490
+875
+5% +$62.7K 0.16% 136
2014
Q3 		$1.19M Sell
16,615
-185
-1% -$13.5K 0.17% 120
2014
Q2 		$1.25M Sell
16,800
-3,775
-18% -$273K 0.18% 118
2014
Q1 		$1.33M Sell
20,575
-670
-3% -$43.3K 0.19% 127
2013
Q4 		$1.26M Sell
21,245
-2,750
-11% -$149K 0.18% 130
2013
Q3 		$1.25M Sell
23,995
-675
-3% -$33.9K 0.2% 124
2013
Q2 		$1.17M Buy
+24,670
New +$1.26M 0.2% 125

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pittenger & Anderson Inc's AZN Position: Q2 2026 in Review

Pittenger & Anderson Inc reduced its AstraZeneca (AZN) stake by 0.04% in Q2 2026, selling an estimated $2.44K and leaving 32,459 shares worth $6.15M. The position accounts for 0.22% of the portfolio, ranked #98.

Pittenger & Anderson Inc first reported a position in AZN in Q2 2013 and has held it in 25 quarters since. The position peaked at $6.4M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pittenger & Anderson Inc held 32,459 shares of AstraZeneca worth $6.15M as of Q2 2026.
  • Pittenger & Anderson Inc sold 13 AstraZeneca shares in Q2 2026, an estimated $2.44K.
  • AstraZeneca made up 0.22% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #98 holding.
  • Pittenger & Anderson Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 25 quarters since.
  • Pittenger & Anderson Inc's AstraZeneca position peaked at $6.4M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.